Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBurping a lot on Mounjaro is one of the most commonly reported digestive side effects, and it typically comes down to one thing: tirzepatide slows the rate at which your stomach empties. Food and gas move through your upper gut more slowly than usual, and air that would otherwise pass quietly tends to come back up instead. It settles for most people within a few days to a couple of weeks of starting a new dose. That said, if you're finding the belching persistent, disruptive or accompanied by other symptoms, there are practical steps worth knowing about — and some situations where it's right to speak to a clinician. These are prescription-only medicines assessed individually by a prescriber; how they affect you depends on your own physiology, your dose, and how your treatment is progressing.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
For most people, belching on tirzepatide is exactly what it looks like: a side effect of slowed gastric emptying, not a sign that anything has gone wrong. Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) and one of the effects is that food lingers in the stomach for longer. Gas produced during digestion, or air swallowed while eating, has more time to accumulate before the gut processes it onward. The result is burping, sometimes quite a lot of it, especially in the first few days after a dose increase, and our Mounjaro burping page goes into detail on why this happens and what typically helps. The NHS medicines page for tirzepatide lists burping alongside nausea, indigestion and reflux as expected gastrointestinal effects.
Where it becomes worth paying closer attention is when burping arrives alongside severe or persistent stomach pain, particularly pain that spreads toward your back, or vomiting that you cannot keep fluids down through. Those symptoms can indicate something more serious, such as pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Ordinary belching after a meal is not that. But if something feels different, urgent help is the right call. Details on distinguishing normal from concerning symptoms are covered on our Mounjaro side effects page.
One thing patients tell us they wish they'd known: the jump from one dose to the next often brings symptoms back temporarily, even if the previous dose had settled. That's normal. It doesn't mean the medicine has stopped agreeing with you.
Because the mechanism is mechanical (food sitting longer in the stomach) what and how you eat has a direct bearing on how much burping you experience. Tirzepatide isn't something you can simply take and then eat exactly as before; the slower gastric transit means that large meals, foods high in fat or fibre, and eating quickly all compound the problem. Carbonated drinks are a particular culprit: bubbles you'd previously have processed without noticing now have more opportunity to travel upward.
Practical steps that tend to help: smaller plates at meal times rather than reducing the number of meals, chewing more thoroughly so less air is swallowed, and sitting upright for at least twenty minutes after eating. Some people find that eating the main meal earlier in the day, when they have time to stay active afterward, eases digestion generally. These are not medical instructions; they are the kind of adjustments that come up most often in clinical conversations about managing GI symptoms on this treatment. Your prescriber or the Patient Information Leaflet that comes with your pen is the right place to confirm anything specific to your dose and health picture. For a more focused look at practical strategies, reducing burping on Mounjaro covers these in more detail.
If you're curious about cost or considering switching from another provider, our Mounjaro pricing page explains what a legitimate private prescription should include.
This is the question that actually matters for a lot of people reading this: is the belching bad enough to reconsider the treatment? That is a genuine clinical decision, and it belongs in a conversation with a prescriber rather than a forum. But here's what informs it.
Burping and other upper GI symptoms are dose-related. Many people who find 5mg uncomfortable settle well at 2.5mg, and move up only once their gut has adjusted. If you're burping heavily, your prescriber may advise staying at your current dose longer before stepping up, rather than pushing through on schedule. That is a legitimate clinical choice, not a failure. Stopping entirely because of manageable GI symptoms, without that conversation, means missing out on a titration approach that was built precisely to handle early-stage discomfort.
For a small proportion of people, upper GI symptoms (including persistent belching, bloating and reflux) are severe enough that tirzepatide isn't the right fit. That's also a real outcome, and a prescriber can explore whether a different approach suits you better. The question of whether the burping is occasional and inconvenient, versus constant and affecting your daily life, is the dividing line. If it's the latter, that conversation is overdue. You can read more about tirzepatide as a treatment on our Mounjaro overview page, or explore weight-loss treatment options more broadly if you're weighing alternatives. Our clinical team reviews every consultation personally, a prescriber reads your history, not a bot.
The more specific you can be, the more useful the conversation. Try to note when the burping is worst (immediately after eating, later in the day, after specific foods), whether it has changed since your last dose increase, and whether it's accompanied by anything else, heartburn, nausea, a sense of fullness that arrives very early in a meal. All of that helps a prescriber understand whether you're dealing with a predictable adjustment effect or something that warrants a closer look.
At nume, your consultation is reviewed the same day by a GPhC-registered prescriber. If you have concerns about side effects between orders, our team is reachable seven days a week for aftercare. And if you're still deciding whether to start or are considering a clinical review of your current symptoms, our frequently asked questions cover many of the common concerns first-time and ongoing patients raise. You can also find peer-level discussion of this specific symptom on our tirzepatide burping page, which draws together what's known from clinical evidence.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.